-+ 0.00%
-+ 0.00%
-+ 0.00%

ASCLETIS ANNOUNCES ORAL DISCUSSION OF ASC36_35 FDC PRECLINICAL DATA DEMONSTRATING SUPERIOR WEIGHT LOSS TO ELORALINTIDE/TIRZEPATIDE COMBINATION AT THE 62ND EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING

Reuters·07/23/2026 00:10:00

Please log in to view news